2013 ESH/ESC Guidelines for the management of arterial hypertension
By G. Mancia, R. Fagard, K. Narkiewicz, J. Redón, A. Zanchetti, M. Böhm, T. Christiaens, R. Cífková, G. De Backer, A. Dominiczak and 15 more. Blood Pressure, 2007
6,166 citations recorded by the source corpus.
Because of new evidence on several diagnostic and therapeutic aspects of hypertension, the present guidelines differ in many respects from the previous ones. Some of the most important differences are listed below: 1. Epidemiological data on hypertension and BP control in Europe. 2. Strengthening of the prognostic value of home blood pressure monitoring (HBPM) and of its role for diagnosis and management of hypertension, next to ambulatory blood pressure monitoring (ABPM). 3. Update of the prognostic significance of night-time BP, white-coat hypertension and masked hypertension. 4. Re-emphasis on integration of BP, cardiovascular (CV) risk factors, asymptomatic organ damage (OD) and clinical complications for total CV risk assessment. 5. Update of the prognostic significance of asymptomatic OD, including heart, blood vessels, kidney, eye and brain. 6. Reconsideration of the risk of overweight and target body mass index (BMI) in hypertension. 7. Hypertension in young people. 8. Initiation of antihypertensive treatment. More evidence-based criteria and no drug treatment of high normal BP. 9. Target BP for treatment. More evidence-based criteria and unified target systolic blood pressure (SBP) (<140 mmHg) in both higher and lower CV risk patients. 10. Liberal approach to initial monotherapy, without any all-ranking purpose. 11. Revised schema for priorital two-drug combinations. 12. New therapeutic algorithms for achieving target BP. 13. Extended section on therapeutic strategies inspecial conditions. 14. Revised recommendations on treatment of hypertensionin the elderly. 15. Drug treatment of octogenarians. 16. Special attention to resistant hypertension and newtreatment approaches. 17. Increased attention to OD-guided therapy. 18. New approaches to chronic management of hypertensive disease.
Subfields: Cardiology and Cardiovascular Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/e1224b5e049bb20854838b8b4f39c34ed0062f5a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- S. Umemura
- H. Arima
- Shuji Arima
- K. Asayama
- T. Ohkubo
- K. Matsumura
- S. Ito
- S. Ueda
Citations in the corpus
- The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019) (2019, background): “sectional/follow-up surveys in USA/Europe and Japan as well as their meta-analysis [126, 134, 144, 145, 147].”